These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25549044)

  • 1. Minireview: nuclear receptor regulation of osteoclast and bone remodeling.
    Jin Z; Li X; Wan Y
    Mol Endocrinol; 2015 Feb; 29(2):172-86. PubMed ID: 25549044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic regulation of osteoclast development and function.
    Teitelbaum SL; Ross FP
    Nat Rev Genet; 2003 Aug; 4(8):638-49. PubMed ID: 12897775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast diseases.
    Helfrich MH
    Microsc Res Tech; 2003 Aug; 61(6):514-32. PubMed ID: 12879419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Receptors in Skeletal Homeostasis.
    Zuo H; Wan Y
    Curr Top Dev Biol; 2017; 125():71-107. PubMed ID: 28527581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects].
    Ueland T; Bollerslev J; Mosekilde L
    Ugeskr Laeger; 2002 Jul; 164(27):3526-30. PubMed ID: 12116680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New paradigms in the regulation of bone metabolism].
    Rosa-Rañal M; de la Cruz DA; Lorena-Rubio Y; Larrea F
    Rev Invest Clin; 2001; 53(4):362-9. PubMed ID: 11599485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone and Stem Cells. Molecular mechanisms of the differentiation and activation of osteoclasts derived from hematopoietic cells].
    Hayashi M; Nakashima T
    Clin Calcium; 2014 Apr; 24(4):487-500. PubMed ID: 24681494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL-RANK signaling in osteoclastogenesis and bone disease.
    Wada T; Nakashima T; Hiroshi N; Penninger JM
    Trends Mol Med; 2006 Jan; 12(1):17-25. PubMed ID: 16356770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone.
    Faucheux C; Horton MA; Price JS
    J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.
    Menéndez-Gutiérrez MP; Rőszer T; Fuentes L; Núñez V; Escolano A; Redondo JM; De Clerck N; Metzger D; Valledor AF; Ricote M
    J Clin Invest; 2015 Feb; 125(2):809-23. PubMed ID: 25574839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast formation and differentiation: an overview.
    Soysa NS; Alles N; Aoki K; Ohya K
    J Med Dent Sci; 2012 Nov; 59(3):65-74. PubMed ID: 23897045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
    Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
    J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.
    Suda T; Takahashi N; Udagawa N; Jimi E; Gillespie MT; Martin TJ
    Endocr Rev; 1999 Jun; 20(3):345-57. PubMed ID: 10368775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling.
    Wang S; Maruyama EO; Martinez J; Lopes J; Hsu T; Wu W; Hsu W; Maruyama T
    Elife; 2023 Feb; 12():. PubMed ID: 36752600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.